Hepatic AMPK activity is considerably diminished in NAFL and NASH (73, 74), and this is linked to the incidence of NAFLD (75), whereas AMPK activation improves NAFL and NASH (74, 76). The gene discussed is PRKAA2; the disease is non-alcoholic fatty liver.